Lipworth, B., Chan, R. & Kuo, C. 2020, 'Tocilizumab for severe COVID-19 pneumonia', The Lancet Rheumatology, 2(11), pp. e660-e660. https://doi.org/10.1016/S2665-9913(20)30283-6